HealthWise KnowledgeBase
Leukotriene Pathway Modifiers for Long-Term Control of Asthma
How Well It Works
Research shows that compared with a Reference placebo Opens New Window, leukotriene pathway modifiers:
- Reduced symptoms in adults.Reference 1
- Improved lung function in children. There are conflicting reports on whether they improved symptoms.Reference 2
But leukotriene pathway modifiers are not as effective as inhaled corticosteroids. And adding leukotrienes to inhaled corticosteroids is not as effective as adding long-acting beta2-agonists to inhaled corticosteroids.Reference 1
| By: | Reference Healthwise Staff | Last Revised: February 13, 2011 |
| Medical Review: | Reference E. Gregory Thompson, MD - Internal Medicine
Reference Rohit K Katial, MD - Allergy and Immunology |
|
© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.
